MX9603999A - Tratamiento de nefropatia diabetica con valsartan. - Google Patents
Tratamiento de nefropatia diabetica con valsartan.Info
- Publication number
- MX9603999A MX9603999A MX9603999A MX9603999A MX9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A MX 9603999 A MX9603999 A MX 9603999A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetic nephropathy
- treatment
- valsartan
- formula
- angiotensin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
El antagonista de angiotensina II de la Formula: (Ver Formula) y las sales farmacéuticamente aceptables del mismo, se pueden utilizar para el tratamiento terapéutico de nefropatía diabética.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH80094 | 1994-03-17 | ||
| CH800/94-1 | 1994-03-17 | ||
| PCT/EP1995/000831 WO1995024901A1 (en) | 1994-03-17 | 1995-03-07 | Treatment of diabetic nephropathy with valsartan |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9603999A true MX9603999A (es) | 1997-12-31 |
| MXPA96003999A MXPA96003999A (es) | 1998-09-18 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| HU9602536D0 (en) | 1996-11-28 |
| WO1995024901A1 (en) | 1995-09-21 |
| FI963611A0 (fi) | 1996-09-13 |
| CN1143908A (zh) | 1997-02-26 |
| FI963611A7 (fi) | 1996-09-13 |
| JPH09510225A (ja) | 1997-10-14 |
| AU1850695A (en) | 1995-10-03 |
| CA2184712A1 (en) | 1995-09-21 |
| HUT76542A (en) | 1997-09-29 |
| CZ268896A3 (en) | 1997-03-12 |
| FI963611L (fi) | 1996-09-13 |
| EP0750500A1 (en) | 1997-01-02 |
| SK117996A3 (en) | 1997-03-05 |
| PL316259A1 (en) | 1997-01-06 |
| BR9507086A (pt) | 1997-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2191192T3 (es) | Tienopirimidinas. | |
| TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
| ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
| EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
| ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| ES2058342T3 (es) | Pirroles, pirazoles y triazoles sustituidos antagonistas de la angiotensina ii. | |
| SE9900961D0 (sv) | Novel compounds | |
| EA200200742A1 (ru) | 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии | |
| SE9802208D0 (sv) | Novel compounds | |
| PE20030061A1 (es) | 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4 | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| SE9900070D0 (sv) | New use | |
| AR023597A1 (es) | Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion delconjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos ansiedad-depresion | |
| EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
| SE9802209D0 (sv) | Novel compounds | |
| MX9403032A (es) | Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos. | |
| ATE325115T1 (de) | Pyrimidinderivate als selektive cox-2-inhibitoren | |
| BR0307317A (pt) | Tratamento de combinação para infartação miocardial aguda | |
| ES2191908T3 (es) | 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido. | |
| ATE343576T1 (de) | 7-azaindolderivate als cox2-inhibitoren | |
| MX9603999A (es) | Tratamiento de nefropatia diabetica con valsartan. | |
| AR023452A1 (es) | Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor |